# QA Report

## Identity

| Field | Value |
|---|---|
| QA Report ID | QA-PP-0161 |
| PP ID | PP-0161 |
| Title | H. pylori Eradication for Gastric Cancer Prevention |
| Version | 1.0.0 |
| Status | PASS |

# Layer 1 — Content QA

| Check | Result |
|---|---|
| One atomic clinical question | PASS |
| Intervention-focused scope | PASS |
| Primary prevention | PASS |
| Secondary prevention | PASS |
| Post-early-gastric-cancer eradication | PASS |
| Asymptomatic/high-risk context | PASS |
| Regimen-selection principle | PASS |
| Adherence/completion | PASS |
| Confirmation-of-eradication concept | PASS |
| Treatment-failure principle | PASS |
| Reinfection/recurrence | PASS |
| Antimicrobial stewardship | PASS |
| Residual-risk explanation | PASS |
| Patient misconceptions | PASS |

# Layer 2 — Clinical QA

| Check | Result |
|---|---|
| PP-0160 prevention rationale separated from PP-0161 intervention | PASS |
| Historical regimens not presented as current universal prescriptions | PASS |
| NCCN current regimen-selection principle preserved | PASS |
| No unsupported contemporary antibiotic algorithm invented | PASS |
| No unsupported test-of-cure protocol invented | PASS |
| No universal family-wide eradication rule | PASS |
| Treatment failure routed to reassessment | PASS |
| Residual cancer risk preserved | PASS |
| Precursor-lesion management delegated | PASS |
| Secondary prevention after early gastric cancer represented | PASS |

# Layer 3 — Evidence QA

| Check | Result |
|---|---|
| NCI H. pylori and Cancer used | PASS |
| NCI Prevention PDQ used | PASS |
| NCCN v2.2026 used | PASS |
| Shandong RCT traceable | PASS |
| Family-history RCT traceable | PASS |
| Metachronous-cancer evidence traceable | PASS |
| Post-curative ER recommendation traceable | PASS |
| ACG/Maastricht delegation traceable | PASS |
| Resistance concern traceable | PASS |
| Reinfection/family-transmission evidence traceable | PASS |
| Source gaps explicitly documented | PASS |

# Layer 4 — Educational QA

| Check | Result |
|---|---|
| Plain-language framing | PASS |
| One concept per block | PASS |
| Medical terms explained | PASS |
| Neutral tone | PASS |
| No sensational language | PASS |
| Historical vs current evidence clearly separated | PASS |
| Patient-facing misconceptions addressed | PASS |

# Layer 5 — Boundary / Overlap QA

## PP-0160 — H. pylori and Gastric Cancer Prevention

PP-0160 owns:

> why eradication matters and what prevention evidence shows.

PP-0161 owns:

> the eradication intervention framework.

**Result: PASS**

## PP-0012 — Helicobacter pylori

PP-0012 owns general infection biology.

PP-0161 uses only the infection concepts necessary to explain eradication.

**Result: PASS**

## PP-0155 — Family History

PP-0155 owns family history as a risk factor.

PP-0161 uses it only to contextualize prevention evidence.

**Result: PASS**

## PP-0165 / PP-0166

Detailed atrophic gastritis and intestinal metaplasia remain delegated.

**Result: PASS**

## PP-0170

Generic/high-risk gastric-cancer screening remains delegated.

**Result: PASS**

## H. pylori Testing / Test-of-Cure

Detailed diagnostic methodology remains outside current PP-0161.

**Result: PASS**

# Layer 6 — Safety QA

| Safety Check | Result |
|---|---|
| No individualized prescription | PASS |
| No unsupported current antibiotic regimen | PASS |
| No unsupported treatment duration | PASS |
| No unsupported salvage algorithm | PASS |
| No unsupported test-of-cure timing | PASS |
| No claim of zero cancer risk after eradication | PASS |
| Antimicrobial resistance addressed | PASS |
| Appropriate follow-up concept preserved | PASS |

# Layer 7 — Governance QA

The Gold Specification requires every PP to be:
- atomic;
- patient-centered;
- evidence-based;
- traceable;
- reusable;
- maintainable;
- bounded against other PPs.

It also requires the four governed artifacts: CKO, Knowledge Passport, Primary Evidence Package, and QA Report. fileciteturn31file5turn31file13

PP-0161 is explicitly registered as **H. pylori Eradication for Gastric Cancer Prevention**, immediately downstream of PP-0160. fileciteturn31file14

The approved workflow requires immediate production after the Decision Batch is locked; no additional format/depth confirmation is required.

**Governance result: PASS**

# Final QA Decision

**PASS**

PP-0161 is source-grounded and architecturally separated from PP-0160. The known limitation regarding contemporary eradication regimens is explicitly preserved rather than filled from unsupported knowledge.

# Final Status

**PASS — GOLD — READY FOR INTEGRATION**
